Page 9 - Pharmaceutical Companies

Vardhman Health to invest Rs 100 crore in adult immunisation outreach

Company earned Rs 500 crore as revenue in FY21 and it plans to double it to over Rs 1,000 crore.

JB Chemicals: New launches, market share gains to drive growth

Key chronic segments have helped the JB Chemicals outperform the Indian pharma market.

Asset monetisation, sales uptick in US key triggers for Glenmark Pharma

The India business is expected to post double digit growth in FY22

Indegene's valuation reaches $700 mn; raises $200 mn from Carlyle, Brighton

Given the wider adoption of digital initiatives within the healthcare industry, Indegene plans to use the funds to accelerate its M&A (merger and acquisition) and global expansion plans

Eris Lifesciences Q3 net up 42% to Rs 90 cr, total income rises by 14%

Overall, the company saw decent growth in its product segments, led by cardio metabolic and vitamin-mineral-nutrients

Reform and incentives

Govt must seek to benefit manufacturing more broadly

As domestic sales decline, drug makers focus on exports to sustain growth

During April-July, drug makers exported products worth $ 7.4 billion, a growth of 9.5 per cent on year on year basis

GMM Pfaudler says ready to respond to charges on unusual trades during OFS

The stock continues to fall, and is down over 36 per cent since September 15

Export boost to help pharma sector come out unscathed from Covid-19: CRISIL

Exports and domestic formulations account for an almost equal share in the Rs 2.8-trillion domestic pharma sector, CRISIL said

Gilead nears deal to buy Immunomedics for more than $20 billion: Report

Discussions between Gilead and Immunomedics were initially centered around a partnership before shifting to a full-fledged takeover negotiation

Zydus Cadila gets approval from USFDA for muscle relaxant injection

Drugfirm Zydus Cadila has received final approval from the US health regulator to market Cisatracurium BesylateInjection, a muscle relaxant given before general anaesthesia

Covid-19 prescription: Pharma players shift their focus over the counter

The pandemic pushes pharma companies to look at drugs that held promise in transitioning to over the counter segment

Firms and lenders provisions for Covid-related losses cross Rs 27,000 cr

Inventory, impairment losses also run into thousands of crores across March and June, Business Standard analysis shows

Chemist body warns against Amazon's entry into online pharmacy space

The letter has also been addressed to Prime Minister Narendra Modi, Union Home Minister Amit Shah and other top ministers and government officials

Gilead puts $2,340 price tag for coronavirus drug, faces criticism

The maker of a drug shown to shorten recovery time for severely ill patients says it will charge $2,340 for a typical treatment course for people covered by govt health programmes in the US

Atrimed Pharma launch 'Plant Science' range hand sanitiser to join the fight against COVID-19 with subsidised pricing

Atrimed Pharma launch 'Plant Science' range hand sanitiser to join the fight against COVID-19 with subsidised pricing

Lincoln Pharma gets entry into Europe, will sell derma, gastro drugs

Receives Germany's GMP certification for its Khatraj plant, can sell to all 27 EU markets

Four in a lift, facing the wall: Office etiquette in Covid-19 times

The second of a 3-part series discusses precautions taken by firms to keep employees safe

Surge in demand for preventive drugs seen post lockdown, Ayurveda in focus

Country is testing to see if herbal medicines such as ashwagandha can act as preventive instead of HCQ for Covid-19

Covid-19 impact: Indian firms look to fill in for US' Famotidine crunch

Some see this as an opportunity for Indian firms like Alembic, Aurobindo who make both the bulk drug and the formulation